VIRS Performance — Pacer BioThreat Strategy ETF
Data updated: 2024-09-27
VIRS returned +18.99% over one year to Jul 2024. The annualised 3-year return is +5.80%. Against its US Large Blend category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $118, against $122 for the category, and to $119 over one year, against $118. Volatility over the past three years was 17.59% a year. In the 12 months to Jul 2024 the fund took in a net $2.4M, and assets reached $3.78M.
VIRS Growth of $100
What $100 invested in Pacer BioThreat Strategy ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Blend category average over the same months.
| Period | VIRS | Category average |
|---|---|---|
| 1 year (Aug 2023 – Jul 2024) | $119 | $118 |
| 3 years (Aug 2021 – Jul 2024) | $118 | $122 |
| Since data start (Jun 2020 – Jul 2024) | $160 | $171 |
VIRS Trailing Returns
Total returns to Jul 2024, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +18.99% |
| 3 years (annualised) | +5.80% |
VIRS Annual Returns
Calendar-year total returns of Pacer BioThreat Strategy ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2024 (Jan–Jul) | +17.45% |
| 2023 | +15.67% |
| 2022 | −17.94% |
| 2021 | +25.23% |
| 2020 (Jun–Dec) | +14.51% |
VIRS Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | +2.5% | +6.5% | +2.9% | −4.8% | +4.2% | +1.5% | +3.9% | — | — | — | — | — |
| 2023 | +3.7% | −3.9% | +4.3% | +0.2% | +0.7% | +6.1% | +2.6% | −1.0% | −5.8% | −4.6% | +7.1% | +6.2% |
| 2022 | −9.2% | −5.0% | +3.1% | −7.6% | +0.4% | −6.5% | +7.3% | −6.8% | −5.3% | +8.7% | +7.1% | −3.5% |
| 2021 | +4.6% | −4.1% | +3.5% | +3.6% | +1.6% | +4.5% | +3.2% | +3.6% | −4.6% | +6.7% | −0.2% | +1.0% |
| 2020 | — | — | — | — | — | +1.8% | +6.4% | +5.6% | −0.8% | −3.7% | +6.1% | −1.3% |
VIRS Risk
Risk measures from monthly returns over Aug 2021 – Jul 2024.
- 3-year volatility (annualised): 17.59%
- 3-year Sharpe ratio: 0.07 (vs 4.5% risk-free rate)
- Best month: +8.73% (Oct 2022)
- Worst month: −9.24% (Jan 2022)
VIRS Fund Flows
Monthly money in and out of Pacer BioThreat Strategy ETF, from SEC Form N-PORT.
- 12-month net flow: $2.4M
- 12-month gross sales (incl. reinvestments): $1.7M
- Sales ÷ redemptions: -2.54×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2024 | $0 | $0 | $0 |
| Jun 2024 | $929K | $929K | −$532 |
| May 2024 | $0 | $0 | $0 |
| Apr 2024 | $0 | $0 | $0 |
| Mar 2024 | $0 | $0 | $0 |
| Feb 2024 | $0 | $0 | $0 |
| Jan 2024 | $813K | −$819K | $1.6M |
| Dec 2023 | $0 | −$796K | $796K |
| Nov 2023 | $0 | $0 | $0 |
| Oct 2023 | $0 | $0 | $0 |
| Sep 2023 | $0 | $0 | $0 |
| Aug 2023 | $0 | $0 | $0 |
VIRS Assets Under Management
Net assets of Pacer BioThreat Strategy ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2024-07-31 | $3.78M |
| 2024-04-30 | $3.45M |
| 2024-01-31 | $3.31M |
| 2023-10-31 | $3.56M |
| 2023-07-31 | $4.01M |
| 2023-04-30 | $3.67M |
| 2023-01-31 | $3.66M |
| 2022-10-31 | $4.11M |
| 2022-07-31 | $5.72M |
| 2022-04-30 | $5.70M |
| 2022-01-31 | $7.89M |
| 2021-10-31 | $6.91M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.